A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival (original) (raw)

• 1. Albert FK, , Forsting M, & Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–61, 1994 Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. **Neurosurgery 34:**45–61, 1994
• PubMed
  Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45– 61, 1994 Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–61, 1994
  )| false
• Search Google Scholar
• Export Citation
• 1. Ammirati M, , Galicich JH, & Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607–614, 1987 Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas. **Neurosurgery 21:**607–614, 1987
• Crossref
• PubMed
  Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21: 607– 614, 1987 Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607–614, 1987 10.1227/00006123-198711000-00001
  )| false
• Search Google Scholar
• Export Citation
• 1. Ammirati M, , Vick N, & Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201–206, 1987 Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. **Neurosurgery 21:**201–206, 1987
• Crossref
• PubMed
  Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21: 201– 206, 1987 Ammirati M, Vick N, Liao Y, et al: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201–206, 1987 10.1227/00006123-198708000-00012
  )| false
• Search Google Scholar
• Export Citation
• 1. Andreou J, , George AE, & Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. AJNR 4:488–490, 1983 Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. **AJNR 4:**488–490, 1983
• PubMed
  Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. AJNR 4: 488– 490, 1983 Andreou J, George AE, Wise A, et al: CT prognostic criteria of survival after malignant glioma surgery. AJNR 4:488–490, 1983
  )| false
• Search Google Scholar
• Export Citation
• 1. Avellanosa AM, , West CR, & Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine. Cancer 44:839–846, 1979 Avellanosa AM, West CR, Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine. **Cancer 44:**839–846, 1979
• Crossref
• PubMed
  Avellanosa AM, West CR, Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine. Cancer 44: 839– 846, 1979 Avellanosa AM, West CR, Tsukada Y, et al: Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine. Cancer 44:839–846, 1979 10.1002/1097-0142(197909)44:3<839::AID-CNCR2820440308>3.0.CO;2-1
  )| false
• Search Google Scholar
• Export Citation
• 1. Burger PC, & Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme. Cancer 59:1617–1625, 1987 Burger PC, Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme. **Cancer 59:**1617–1625, 1987
• Crossref
• PubMed
  Burger PC, Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617– 1625, 1987 Burger PC, Green SB: Patient age, histological features, and length of survival in patients with glioblastoma multiforme. Cancer 59:1617–1625, 1987 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X
  )| false
• Search Google Scholar
• Export Citation
• 1. Cox DR: Regression models and life tables. J R Stat Soc B 34:187–220, 1972 Cox DR: Regression models and life tables. **J R Stat Soc B 34:**187–220, 1972
• PubMed
  Cox DR: Regression models and life tables. J R Stat Soc B 34: 187– 220, 1972 Cox DR: Regression models and life tables. J R Stat Soc B 34:187–220, 1972
  )| false
• Search Google Scholar
• Export Citation
• 1. Curran WJ Jr, , Scott CB, & Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:219–227, 1992 Curran WJ Jr, Scott CB, Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. **J Neurooncol 12:**219–227, 1992
• Crossref
• PubMed
  Curran WJ Jr, Scott CB, Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12: 219– 227, 1992 Curran WJ Jr, Scott CB, Horton J, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:219–227, 1992 10.1007/BF00172709
  )| false
• Search Google Scholar
• Export Citation
• 1. Daumas-Duport C, , Scheithauer B, & O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152–2165, 1988 Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. **Cancer 62:**2152–2165, 1988
• Crossref
• PubMed
  Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152– 2165, 1988 Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152–2165, 1988 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T
  )| false
• Search Google Scholar
• Export Citation
• 1. Earnest F IV, , Kelly PJ, & Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827, 1988 Earnest F IV, Kelly PJ, Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy. **Radiology 166:**823–827, 1988
• Crossref
• PubMed
  Earnest F IV, Kelly PJ, Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166: 823– 827, 1988 Earnest F IV, Kelly PJ, Scheithauer BW, et al: Cerebral astrocytomas: histopathological correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827, 1988 10.1148/radiology.166.3.2829270
  )| false
• Search Google Scholar
• Export Citation
• 1. Fadul C, , Wood J, & Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38:1374–1379, 1988 Fadul C, Wood J, Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. **Neurology 38:**1374–1379, 1988
• Crossref
• PubMed
  Fadul C, Wood J, Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38: 1374– 1379, 1988 Fadul C, Wood J, Thaler H, et al: Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38:1374–1379, 1988 10.1212/WNL.38.9.1374
  )| false
• Search Google Scholar
• Export Citation
• 1. Gehan EA, & Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:189–195, 1977 Gehan EA, Walker MD: Prognostic factors for patients with brain tumors. **Natl Cancer Inst Monogr 46:**189–195, 1977
• PubMed
  Gehan EA, Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46: 189– 195, 1977 Gehan EA, Walker MD: Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46:189–195, 1977
  )| false
• Search Google Scholar
• Export Citation
• 1. Gilbert H, , Kagan AR, & Cassidy F, et al: Glioblastoma multiforme is not a uniform disease. Cancer Clin Trials 4:87–89, 1981 Gilbert H, Kagan AR, Cassidy F, et al: Glioblastoma multiforme is not a uniform disease. **Cancer Clin Trials 4:**87–89, 1981
• PubMed
  Gilbert H, Kagan AR, Cassidy F, et al: Glioblastoma multiforme is not a uniform disease. Cancer Clin Trials 4: 87– 89, 1981 Gilbert H, Kagan AR, Cassidy F, et al: Glioblastoma multiforme is not a uniform disease. Cancer Clin Trials 4:87–89, 1981
  )| false
• Search Google Scholar
• Export Citation
• 1. Hammoud MA, , Sawaya R, & Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65–73, 1996 Hammoud MA, Sawaya R, Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme. **J Neurooncol 27:**65–73, 1996
• Crossref
• PubMed
  Hammoud MA, Sawaya R, Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27: 65– 73, 1996 Hammoud MA, Sawaya R, Shi W, et al: Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65–73, 1996 10.1007/BF00146086
  )| false
• Search Google Scholar
• Export Citation
• 1. Harsh GR IV, , Levin VA, & Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615–621, 1987 Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. **Neurosurgery 21:**615–621, 1987
• Crossref
• PubMed
  Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21: 615– 621, 1987 Harsh GR IV, Levin VA, Gutin PH, et al: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615–621, 1987 10.1227/00006123-198711000-00002
  )| false
• Search Google Scholar
• Export Citation
• 1. Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227–231, 1999 Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. **J Neurooncol 42:**227–231, 1999
• Crossref
• PubMed
  Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42: 227– 231, 1999 Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227–231, 1999 10.1023/A:1006118018770
  )| false
• Search Google Scholar
• Export Citation
• 1. Kaplan EL, & Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958 Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. **J Am Stat Assoc 53:**457–481, 1958
• Crossref
• PubMed
  Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457– 481, 1958 Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958 10.1080/01621459.1958.10501452
  )| false
• Search Google Scholar
• Export Citation
• 1. Kelly PJ: Stereotactic biopsy and resection of thalamic astrocytomas. Neurosurgery 25:185–195, 1989 Kelly PJ: Stereotactic biopsy and resection of thalamic astrocytomas. **Neurosurgery 25:**185–195, 1989
• Crossref
• PubMed
  Kelly PJ: Stereotactic biopsy and resection of thalamic astrocytomas. Neurosurgery 25: 185– 195, 1989 Kelly PJ: Stereotactic biopsy and resection of thalamic astrocytomas. Neurosurgery 25:185–195, 1989 10.1227/00006123-198908000-00006
  )| false
• Search Google Scholar
• Export Citation
• 1. Kelly PJ, , Daumas-Duport C, & Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874, 1987 Kelly PJ, Daumas-Duport C, Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. **J Neurosurg 66:**865–874, 1987
• Crossref
• PubMed
  Kelly PJ, Daumas-Duport C, Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66: 865– 874, 1987 Kelly PJ, Daumas-Duport C, Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874, 1987 10.3171/jns.1987.66.6.0865
  )| false
• Search Google Scholar
• Export Citation
• 1. Kiwit JC, , Floeth FW, & Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57:76–88, 1996 Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. **Zentralbl Neurochir 57:**76–88, 1996
• PubMed
  Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57: 76– 88, 1996 Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57:76–88, 1996
  )| false
• Search Google Scholar
• Export Citation
• 1. Kleihues P, , Burger PC, & Scheithauer BW, et al: Histological Typing of Tumours of the Central Nervous System, ed 2. New York: Springer-Verlag, 1993 Kleihues P, Burger PC, Scheithauer BW, et al: Histological Typing of Tumours of the Central Nervous System, ed 2. New York: Springer-Verlag, 1993
• PubMed
  Kleihues P, Burger PC, Scheithauer BW, et al: Histological Typing of Tumours of the Central Nervous System, ed 2. New York: Springer-Verlag, 1993 Kleihues P, Burger PC, Scheithauer BW, et al: Histological Typing of Tumours of the Central Nervous System, ed 2. New York: Springer-Verlag, 1993
  )| false
• Search Google Scholar
• Export Citation
• 1. Kreth FW, , Warnke PC, & Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766, 1993 Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. **J Neurosurg 78:**762–766, 1993
• Crossref
• PubMed
  Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762– 766, 1993 Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766, 1993 10.3171/jns.1993.78.5.0762
  )| false
• Search Google Scholar
• Export Citation
• 1. Lai DM, , Lin SM, & Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92:220–226, 1993 Lai DM, Lin SM, Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. **J Formos Med Assoc 92:**220–226, 1993
• PubMed
  Lai DM, Lin SM, Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92: 220– 226, 1993 Lai DM, Lin SM, Tu YK, et al: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92:220–226, 1993
  )| false
• Search Google Scholar
• Export Citation
• 1. Nazzaro JM, & Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. J Neurosurg 73:331–344, 1990 Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. **J Neurosurg 73:**331–344, 1990
• Crossref
• PubMed
  Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. J Neurosurg 73: 331– 344, 1990 Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. J Neurosurg 73:331–344, 1990 10.3171/jns.1990.73.3.0331
  )| false
• Search Google Scholar
• Export Citation
• 1. Newell J, , Ransohoff J, & Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6:325–327, 1988 Newell J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? **J Neurooncol 6:**325–327, 1988
• PubMed
  Newell J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6: 325– 327, 1988 Newell J, Ransohoff J, Kaplan B: Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6:325–327, 1988
  )| false
• Search Google Scholar
• Export Citation
• 1. Nitta T, & Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:2727–2731, 1995 Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. **Cancer 75:**2727–2731, 1995
• Crossref
• PubMed
  Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75: 2727– 2731, 1995 Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:2727–2731, 1995 10.1002/1097-0142(19950601)75:11<2727::AID-CNCR2820751115>3.0.CO;2-H
  )| false
• Search Google Scholar
• Export Citation
• 1. Prados MD, , Gutin PH, & Phillips TL, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23:3–8, 1992 Prados MD, Gutin PH, Phillips TL, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. **Int J Radiat Oncol Biol Phys 23:**3–8, 1992
• Crossref
• PubMed
  Prados MD, Gutin PH, Phillips TL, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23: 3– 8, 1992 Prados MD, Gutin PH, Phillips TL, et al: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23:3–8, 1992 10.1016/0360-3016(92)90537-R
  )| false
• Search Google Scholar
• Export Citation
• 1. Quigley MR, & Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385–389, 1991 Quigley MR, Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. **Neurosurgery 29:**385–389, 1991
• Crossref
• PubMed
  Quigley MR, Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. Neurosurgery 29: 385– 389, 1991 Quigley MR, Maroon JC: The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385–389, 1991 10.1227/00006123-199109000-00008
  )| false
• Search Google Scholar
• Export Citation
• 1. Ringertz N: “Grading” of gliomas. Acta Pathol Microbiol Scand 27:51–64, 1950 Ringertz N: “Grading” of gliomas. **Acta Pathol Microbiol Scand 27:**51–64, 1950
• PubMed
  Ringertz N: “Grading” of gliomas. Acta Pathol Microbiol Scand 27: 51– 64, 1950 Ringertz N: “Grading” of gliomas. Acta Pathol Microbiol Scand 27:51–64, 1950
  )| false
• Search Google Scholar
• Export Citation
• 1. Salcman M: Resection and reoperation in neuro-oncology. Rationale and approach. Neurol Clin 3:831–842, 1985 Salcman M: Resection and reoperation in neuro-oncology. Rationale and approach. **Neurol Clin 3:**831–842, 1985
• Crossref
• PubMed
  Salcman M: Resection and reoperation in neuro-oncology. Rationale and approach. Neurol Clin 3: 831– 842, 1985 Salcman M: Resection and reoperation in neuro-oncology. Rationale and approach. Neurol Clin 3:831–842, 1985 10.1016/S0733-8619(18)31012-0
  )| false
• Search Google Scholar
• Export Citation
• 1. Salcman M: Surgical decision-making for malignant brain tumors. Clin Neurosurg 35:285–313, 1989 Salcman M: Surgical decision-making for malignant brain tumors. **Clin Neurosurg 35:**285–313, 1989
• PubMed
  Salcman M: Surgical decision-making for malignant brain tumors. Clin Neurosurg 35: 285– 313, 1989 Salcman M: Surgical decision-making for malignant brain tumors. Clin Neurosurg 35:285–313, 1989
  )| false
• Search Google Scholar
• Export Citation
• 1. Sawaya R: Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42:303–305, 1999 Sawaya R: Extent of resection in malignant gliomas: a critical summary. **J Neurooncol 42:**303–305, 1999
• Crossref
• PubMed
  Sawaya R: Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42: 303– 305, 1999 Sawaya R: Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42:303–305, 1999 10.1023/A:1006167412835
  )| false
• Search Google Scholar
• Export Citation
• 1. Sawaya R, , Hammoud M, & Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056, 1998 Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. **Neurosurgery 42:**1044–1056, 1998
• Crossref
• PubMed
  Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42: 1044– 1056, 1998 Sawaya R, Hammoud M, Schoppa D, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056, 1998 10.1097/00006123-199805000-00054
  )| false
• Search Google Scholar
• Export Citation
• 1. Scott GM, & Gibberd FB: Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand 61:227–239, 1980 Scott GM, Gibberd FB: Epilepsy and other factors in the prognosis of gliomas. **Acta Neurol Scand 61:**227–239, 1980
• PubMed
  Scott GM, Gibberd FB: Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand 61: 227– 239, 1980 Scott GM, Gibberd FB: Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand 61:227–239, 1980
  )| false
• Search Google Scholar
• Export Citation
• 1. Segall HD, , Destian S, & Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63–77 Segall HD, Destian S, Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63–77
• PubMed
  Segall HD, Destian S, Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63– 77 Segall HD, Destian S, Nelson MD Jr, et al: CT and MR imaging in malignant gliomas, in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp 63–77
  )| false
• Search Google Scholar
• Export Citation
• 1. Shapiro WR, , Green SB, & Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71:1–9, 1989 Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001. **J Neurosurg 71:**1–9, 1989
• Crossref
• PubMed
  Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1– 9, 1989 Shapiro WR, Green SB, Burger PC, et al: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomas. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71:1–9, 1989 10.3171/jns.1989.71.1.0001
  )| false
• Search Google Scholar
• Export Citation
• 1. Shi WM, , Wildrick DM, & Sawaya R: Volumetric measurement of brain tumors from MR imaging. J Neurooncol 37:87–93, 1998 Shi WM, Wildrick DM, Sawaya R: Volumetric measurement of brain tumors from MR imaging. **J Neurooncol 37:**87–93, 1998
• Crossref
• PubMed
  Shi WM, Wildrick DM, Sawaya R: Volumetric measurement of brain tumors from MR imaging. J Neurooncol 37: 87– 93, 1998 Shi WM, Wildrick DM, Sawaya R: Volumetric measurement of brain tumors from MR imaging. J Neurooncol 37:87–93, 1998 10.1023/A:1005944724470
  )| false
• Search Google Scholar
• Export Citation
• 1. Walker MD, , Green SB, & Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329, 1980 Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery. **N Engl J Med 303:**1323–1329, 1980
• Crossref
• PubMed
  Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery. N Engl J Med 303: 1323– 1329, 1980 Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329, 1980 10.1056/NEJM198012043032303
  )| false
• Search Google Scholar
• Export Citation
• 1. Wood JR, , Green SB, & Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338–343, 1988 Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. **J Clin Oncol 6:**338–343, 1988
• Crossref
• PubMed
  Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6: 338– 343, 1988 Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338–343, 1988 10.1200/JCO.1988.6.2.338
  )| false
• Search Google Scholar
• Export Citation